Whan In Pharm Co.,Ltd. (KRX:016580)

Whan In Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-	-	-0	-0	0
Revenue	256,323	259,596	230,394	198,935	177,776	171,705
Revenue Growth (YoY)	1.82%	12.68%	15.81%	11.90%	3.54%	7.87%
Cost of Revenue	172,257	165,931	131,451	100,277	84,416	85,204
Gross Profit	84,066	93,665	98,943	98,658	93,359	86,501
Selling, General & Admin	65,391	67,564	64,470	61,948	55,849	51,936
Research & Development	1,291	771.13	1,072	3,331	2,659	3,312
Amortization of Goodwill & Intangibles	272.24	255.99	194.22	418.32	383.22	349.65
Other Operating Expenses	1,343	1,300	1,311	1,273	1,238	1,093
Operating Expenses	71,617	72,170	68,772	68,847	62,083	58,083
Operating Income	12,449	21,495	30,170	29,810	31,276	28,418
Interest Expense	-27.28	-23.12	-22.66	-51.88	-51.55	-31.42
Interest & Investment Income	2,120	2,971	3,769	2,500	1,821	1,676
Earnings From Equity Investments	870.84	1,981	-1,006	-201.08	-61.86	-31.74
Currency Exchange Gain (Loss)	297.57	-69.24	-141.12	343.44	223.56	-201.3
Other Non Operating Income (Expenses)	370.01	528.81	1,016	153.71	329.1	66.98
EBT Excluding Unusual Items	16,080	26,884	33,785	32,555	33,536	29,897
Gain (Loss) on Sale of Investments	39.33	392.98	1,895	925.83	794.08	1,299
Gain (Loss) on Sale of Assets	-314.87	-330.11	-1,160	-1,897	-6.22	-63.52
Asset Writedown	-	-	-726.43	-1,776	-442.01	-50.27
Pretax Income	15,805	26,947	33,793	29,808	33,882	31,082
Income Tax Expense	637.11	3,566	4,019	6,075	7,423	7,890
Earnings From Continuing Operations	15,168	23,381	29,774	23,734	26,459	23,191
Minority Interest in Earnings	-	-	-	187.76	201.09	196.49
Net Income	15,168	23,381	29,774	23,921	26,660	23,388
Net Income to Common	15,168	23,381	29,774	23,921	26,660	23,388
Net Income Growth	-44.57%	-21.47%	24.47%	-10.27%	13.99%	25.09%
Shares Outstanding (Basic)	15	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15	15
Shares Change (YoY)	1.52%	-	-	-	-	-
EPS (Basic)	978.78	1531.45	1950.23	1566.86	1746.22	1531.91
EPS (Diluted)	978.78	1531.45	1950.23	1566.86	1746.00	1531.91
EPS Growth	-45.39%	-21.47%	24.47%	-10.26%	13.98%	25.09%
Free Cash Flow	5,677	-6,664	-7,334	-16,799	30,931	14,767
Free Cash Flow Per Share	366.36	-436.48	-480.39	-1100.32	2025.98	967.21
Dividend Per Share	300.000	300.000	300.000	300.000	300.000	300.000
Gross Margin	32.80%	36.08%	42.95%	49.59%	52.52%	50.38%
Operating Margin	4.86%	8.28%	13.10%	14.99%	17.59%	16.55%
Profit Margin	5.92%	9.01%	12.92%	12.03%	15.00%	13.62%
Free Cash Flow Margin	2.21%	-2.57%	-3.18%	-8.44%	17.40%	8.60%
EBITDA	22,270	29,970	36,830	34,657	35,478	32,488
EBITDA Margin	8.69%	11.54%	15.99%	17.42%	19.96%	18.92%
D&A For EBITDA	9,821	8,475	6,659	4,847	4,202	4,070
EBIT	12,449	21,495	30,170	29,810	31,276	28,418
EBIT Margin	4.86%	8.28%	13.10%	14.99%	17.59%	16.55%
Effective Tax Rate	4.03%	13.23%	11.89%	20.38%	21.91%	25.39%
Advertising Expenses	-	15,285	12,359	10,387	9,519	7,069

Source: S&P Global Market Intelligence. Standard template. Financial Sources.